(Q28165762)

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

23 March 2024

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

23 March 2024

5

Steffen Massberg

0 references

Meinrad Gawaz

6

object named as

Meinrad Gawaz

0 references

Christian Schulz

3

object named as

Christian Schulz

1 reference

Europe PubMed Central

PubMed publication ID

14568892

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568892

23 March 2024

author name string

Iris Müller

1

0 references

Felicitas Besta

2

0 references

Zhongyan Li

4

0 references

language of work or name

English

0 references

publication date

4 November 2003

0 references

20 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

14568892

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568892

23 March 2024

0 references

108

0 references

issue

18

0 references

page(s)

2195-7

0 references

cites work

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin

23 March 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

23 March 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

23 March 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation

23 March 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Statins do not affect platelet inhibition with clopidogrel during coronary stenting

23 March 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Journal of the American College of Cardiology

23 March 2024

12

41

302A.

2003

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000099507.32936.C0

23 March 2024

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

14568892

1 reference

Consolidated OpenCitations Corpus – April 2017